Trade Report: The ING Groep NV Acquires 5,240 Shares of Humana Inc. (HUM)

The ING Groep NV Acquires 5,240  Shares of Humana Inc. (HUM)

ING Groep NV acquired a new position in shares of Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 5,240 shares of the insurance provider’s stock, valued at approximately $945,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Commonwealth Equity Services Inc boosted its stake in shares of Humana by 0.9% in the first quarter. Commonwealth Equity Services Inc now owns 3,694 shares of the insurance provider’s stock worth $676,000 after buying an additional 33 shares during the last quarter. Daiwa SB Investments Ltd. boosted its stake in shares of Humana by 7.5% in the second quarter. Daiwa SB Investments Ltd. now owns 720 shares of the insurance provider’s stock worth $132,000 after buying an additional 50 shares during the last quarter. LS Investment Advisors LLC boosted its stake in shares of Humana by 1.2% in the second quarter. LS Investment Advisors LLC now owns 5,144 shares of the insurance provider’s stock worth $925,000 after buying an additional 63 shares during the last quarter. Checchi Capital Advisers LLC boosted its stake in shares of Humana by 3.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,196 shares of the insurance provider’s stock worth $395,000 after buying an additional 67 shares during the last quarter. Finally, Regent Investment Management LLC boosted its stake in shares of Humana by 3.5% in the second quarter. Regent Investment Management LLC now owns 4,545 shares of the insurance provider’s stock worth $818,000 after buying an additional 154 shares during the last quarter. 93.24% of the stock is owned by institutional investors.

Shares of Humana Inc. (NYSE:HUM) traded up 0.29% during midday trading on Friday, reaching $177.74. The company’s stock had a trading volume of 861,509 shares. The stock has a 50 day moving average price of $176.80 and a 200-day moving average price of $176.07. Humana Inc. has a 52-week low of $150.00 and a 52-week high of $191.65. The company has a market capitalization of $26.50 billion, a price-to-earnings ratio of 27.31 and a beta of 0.90.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.23 by $0.07. Humana had a return on equity of 11.11% and a net margin of 1.76%. The business had revenue of $14 billion for the quarter, compared to the consensus estimate of $13.59 billion. During the same period last year, the business earned $1.67 EPS. The firm’s revenue was up 2.0% compared to the same quarter last year. Equities research analysts expect that Humana Inc. will post $9.24 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date is Tuesday, October 11th. Humana’s dividend payout ratio (DPR) is currently 18.18%.

A number of brokerages have recently issued reports on HUM. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $198.00 target price for the company in a report on Tuesday. Evercore ISI began coverage on Humana in a report on Thursday, September 22nd. They set a “buy” rating and a $200.00 target price for the company. Credit Suisse Group AG restated a “hold” rating and issued a $188.00 price target on shares of Humana in a report on Tuesday, September 13th. Argus restated a “hold” rating on shares of Humana in a report on Tuesday, August 23rd. Finally, Cantor Fitzgerald restated a “buy” rating on shares of Humana in a report on Monday, August 8th. Five analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Humana presently has an average rating of “Buy” and a consensus target price of $201.00.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Related posts

Leave a Comment